Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beam Therapeutics (BEAM) Preferred Shares Issued (2019)

Historic Preferred Shares Issued for Beam Therapeutics (BEAM) over the last 1 years, with Q1 2019 value amounting to $37.9 million.

  • Beam Therapeutics' Preferred Shares Issued changed N/A to $37.9 million in Q1 2019 from the same period last year, while for Dec 2019 it was $37.9 million, marking a year-over-year change of. This contributed to the annual value of $37.9 million for FY2019, which is N/A changed from last year.
  • Latest data reveals that Beam Therapeutics reported Preferred Shares Issued of $37.9 million as of Q1 2019.
  • Beam Therapeutics' 5-year Preferred Shares Issued high stood at $37.9 million for Q1 2019, and its period low was $37.9 million during Q1 2019.